Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G207 with or without radiation in pediatric recurrent brain tumors
NCT02457845Phase 1Completed
- Start
- May 2016
- Primary completion
- Jun 2020
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
Phase 1, open-label trial of G207 in Malignant Neoplasm Of Brain (2 arms). Primary endpoint: Safety and Tolerability at 15 years. Started May 2016; status: completed.
02
Drugs
G207
03
Conditions
Malignant Neoplasm Of Brain
Beyond the preview
Go deeper on NCT02457845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02457845.